A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals
Salvato in:
Amass, L., ET AL., A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals. Addiction, Vol. 107, no. 1 (2012), p. 142-151.
Ref.
183197
Localizzazione:
SIIS R.696 Archivo
Palabras clave:
Buprenorfina, Drogas ilegales, Drogodependencias, Efectos, Heroína, Opiáceos, Programas de mantenimiento, Reducción de daños, Resultados, Tratamiento médico
Buprenorfina, Drogas ilegales, Drogodependencias, Efectos, Heroína, Opiáceos, Programas de mantenimiento, Reducción de daños, Resultados, Tratamiento médico
Documenti analoghi: A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals
- EFFICACY OF DAILY AND ALTERNATE-DAY DOSING REGIMENS WITH THE COMBINATION BUPRENORPHINE-NALOXONE TABLET
- PREFERENCE FOR BUPRENORPHINE/NALOXONE AND BUPRENORPHINE AMONG PATIENTS RECEIVING BUPRENORPHINE MAINTENANCE THERAPY IN FRANCE: A PROSPECTIVE, MULTICENTER STUDY
- PREDICTORS OF OUTCOME FOR SHORT-TERM MEDICALLY SUPERVISED OPIOID WITHDRAWAL DURING A RANDOMIZED, MULTICENTER TRIAL OF BUPRENORPHINE-NALOXONE AND CLONIDINE IN THE NIDA CLINICAL TRIALS NETWORK DRUG AND ALCOHOL DEPENDENCE
- ABUSE LIABILITY OF INTRAVENOUS BUPRENORPHINE/NALOXONE AND BUPRENORPHINE ALONE IN BUPRENORPHINE-MAINTAINED INTRAVENOUS HEROIN ABUSERS
- A DOUBLE-BLIND, DOUBLE-DUMMY, RANDOMIZED, PROSPECTIVE PILOT STUDY OF THE PARTIAL MU OPIATE AGONIST, BUPRENORPHINE, FOR ACUTE DETOXIFICATION FROM HEROIN
- A RANDOMIZED TRIAL OF EFFECTIVENESS AND COST EFFECTIVENESS OF OBSERVED VERSUS UNOBSERVED ADMINISTRATION OF BUPRENORPHINE NALOXONE FOR HEROIN DEPENDENCE